2023 - Research.com Biology and Biochemistry in South Korea Leader Award
Jong Wan Park mostly deals with Cell biology, Cancer research, Hypoxia, Angiogenesis and Vascular endothelial growth factor A. Jong Wan Park has researched Cell biology in several fields, including HEK 293 cells, Molecular biology and Biochemistry. His Cancer research research incorporates themes from Cyclin A2, Tumor promotion, Gene knockdown and In vivo.
His work carried out in the field of Hypoxia brings together such families of science as Pharmacology and Pathology. His Angiogenesis research integrates issues from Cancer cell, STAT3 and Transcription factor. The study incorporates disciplines such as Endocrinology and Internal medicine in addition to Signal transduction.
Jong Wan Park focuses on Cancer research, Cell biology, Internal medicine, Endocrinology and Cancer cell. Jong Wan Park works in the field of Cancer research, namely Angiogenesis. His Cell biology research is multidisciplinary, incorporating perspectives in Molecular biology, Biochemistry, Hypoxia-inducible factors and Downregulation and upregulation.
His Molecular biology study deals with Transactivation intersecting with Immunoprecipitation. His Cancer cell study incorporates themes from Apoptosis and Cell growth. His Transcription factor study combines topics in areas such as Small interfering RNA, Pharmacology, Gene knockdown and G alpha subunit.
Cancer research, Nasal polyps, Cell biology, Downregulation and upregulation and Cancer cell are his primary areas of study. His Cancer research study integrates concerns from other disciplines, such as Epithelial–mesenchymal transition, Metastasis, Transactivation, Signal transduction and Prostate cancer. The concepts of his Cell biology study are interwoven with issues in Cell migration, Gene knockdown, Hydroxylation, Epigenetics and Histone methylation.
In his work, Transcription factor is strongly intertwined with Gene expression, which is a subfield of Gene knockdown. His studies deal with areas such as Liver cancer, HeLa, Chromatin immunoprecipitation and Transfection as well as Downregulation and upregulation. His work deals with themes such as Extracellular, Membrane, Biophysics and Neutrophil extracellular traps, which intersect with Cancer cell.
His scientific interests lie mostly in Cancer research, Cancer cell, Epithelial–mesenchymal transition, Transactivation and Metastasis. His study in Cancer research is interdisciplinary in nature, drawing from both Signal transduction, GDF15, Fibrosis, Resveratrol and Cell-penetrating peptide. His Cancer cell research includes themes of Tumor necrosis factor alpha, Neddylation, NEDD8 and Immunotherapy.
His Neddylation research is multidisciplinary, incorporating elements of Caveolin 1, Phosphorylation, Cell biology and Cancer. His Epithelial–mesenchymal transition research is multidisciplinary, relying on both Eosinophil, Interferon, Cytokine secretion, Neutrophilia and SMAD. His research in Transactivation intersects with topics in Chemokine and Prostate cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Eun-Jin Yeo;Yang-Sook Chun;Young-Suk Cho;Jinho Kim.
Journal of the National Cancer Institute (2003)
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells
Joo Eun Jung;Hyun Gyu Lee;Ik Hyun Cho;Doo Hyun Chung.
The FASEB Journal (2005)
Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway.
Chan-Hyung Kim;Young-Suk Cho;Yang-Sook Chun;Jong-Wan Park.
Circulation Research (2002)
Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
Hyunsung Choi;Yang-Sook Chun;Seung-Won Kim;Myung-Suk Kim.
Molecular Pharmacology (2006)
Nutritional status of gastric cancer patients after total gastrectomy.
Jae-Moon Bae;Jong-Wan Park;Han-Kwang Yang;Jin-Pok Kim.
World Journal of Surgery (1998)
Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
Yang Sook Chun;Eun Jin Yeo;Eunjoo Choi;Che Ming Teng.
Biochemical Pharmacology (2001)
New anticancer strategies targeting HIF-1.
Eun-Jin Yeo;Yang-Sook Chun;Jong-Wan Park.
Biochemical Pharmacology (2004)
Oxygen-dependent and -independent regulation of HIF-1alpha.
Yang Sook Chun;Myung Suk Kim;Jong Wan Park.
Journal of Korean Medical Science (2002)
Human Arrest Defective 1 Acetylates and Activates β-Catenin, Promoting Lung Cancer Cell Proliferation
Ji Hong Lim;Jong Wan Park;Yang Sook Chun.
Cancer Research (2006)
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
Dong Hoon Shin;Yang Sook Chun;Dong Soon Lee;L. Eric Huang.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: